A Study of BBI503 in Asymptomatic Recurrent Ovarian Cancer Patients With CA-125 Elevation
Clinical trial NCT02432690 · TERMINATED
Trial details
- NCT number
- NCT02432690
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2017-01-02
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.